CoChat
Sign Up
Cited by 146Schizophrenia research and treatmentSubstance Abuse Treatment and OutcomesHomelessness and Social Issues

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Substance Use in Persons With Schizophrenia: Baseline Prevalence and Correlates From the NIMH CATIE Study

Swartz, Marvin S., Wagner, H Ryan, Swanson, Jeffrey W., Stroup, T Scott, McEvoy, Joseph P., Canive, Jose M., Miller, Del D., Reimherr, Fred, McGee, Mark, Khan, Ahsan, Van Dorn, Richard, Rosenheck, Robert A., Lieberman, Jeffrey A.·2006·Journal of Nervous & Mental Disease
DOI 10.1097/01.nmd.0000202575.79453.6e
Open this paper in CoChat — free account

Abstract

This study examined baseline correlates of substance use in the NIMH Clinical Antipsychotic Trials of Intervention Effectiveness project. Approximately 60% of the sample was found to use substances, including 37% with current evidence of substance use disorders. Users (with and without substance use disorders), compared with nonusers, were significantly more likely to be male, be African-American, have lower educational attainment, have a recent period of homelessness, report more childhood conduct problems, have a history of major depression, have lower negative symptom and higher positive symptom scores on the Positive and Negative Syndrome Scale, and have a recent illness exacerbation. Individuals with comorbid substance use disorders were significantly more likely to be male, report more childhood conduct problems, have higher positive symptom scores on the Positive and Negative Syndrome Scale, and have a recent illness exacerbation. These analyses suggest that substance use disorders in schizophrenia are especially common among men with a history of childhood conduct disorder problems and that childhood conduct disorder problems are potent risk factors for substance use disorders in schizophrenia.

Overview

Integrity signals

Registry

Crossref · 10.1097/01.nmd.0000202575.79453.6e

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 4

  1. Alterman, 1986, Recent Developments in Alcoholism (Vol 4, pp 169–189).
  2. Epstein, 1994, Types of Alcoholics: Evidence from Clinical, Experimental and Genetic Research: Annals of the New York Academy of Sciences (Vol 708, pp 187–201).
  3. First, 1996, Structured Clinical Interview for Axes I and II DSM-IV Disorders-Patient Edition (SCID-I/P).
  4. Haywood, 1995, Predicting the “revolving door” phenomenon among patient with schizophrenic, schizoaffective and affective disorders., Am J Psychiatry, 151, 856

Cited by

Sorted by citations

See all 146

Related

See all

Metadata

Authors
Swartz, M. S., Wagner, H. R., Swanson, J. W., Stroup, T. S., McEvoy, J. P., Canive, J. M., Miller, D. D., Reimherr, F., McGee, M., Khan, A., Van Dorn, R., Rosenheck, R. A., & Lieberman, J. A.
Affiliations
  • Duke University (US)
  • University of North Carolina at Chapel Hill (US)
  • University of Iowa (US)
  • University of Utah (US)
Corresponding author
  • Swartz, Marvin S.
  • Wagner, H Ryan
  • Swanson, Jeffrey W.
  • McEvoy, Joseph P.
  • Rosenheck, Robert A.
ORCID
Venue
Journal of Nervous & Mental Disease
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2006-03
Volume
194
Issue
3
Pages
164-172
ISSN
0022-3018 (ISSN-L)
DOI
10.1097/01.nmd.0000202575.79453.6e
OpenAlex
W2093348590
Cited by
146
References
37
Citations by year
2026: 1 · 2025: 1 · 2024: 1 · 2023: 2 · 2022: 6 · 2021: 4 · 2020: 8 · 2019: 5 · 2018: 5 · 2017: 2 · 2016: 6 · 2015: 7 · 2014: 8 · 2013: 7 · 2012: 13
FWCI
10.60
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Nervous and Mental Disease (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Eli Lilly and Company
  • Pfizer
  • University of Missouri
  • National Institutes of Health (n01mh90001-21-0-0)
  • National Institute of Mental Health (N01 MH90001)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Social Sciences › Sociology and Political Science › Homelessness and Social Issues
Keywords
schizophrenia, substance use disorders, comorbidities, child conduct problems, risk factors, negative symptoms, positive symptoms, homelessness, major depressive disorder, African American men, educational attainment
MeSH terms
Cross-Sectional Studies, Double-Blind Method, Female, Humans, Male, Piperazines, Risk Factors, Schizophrenia, Schizophrenic Psychology, Sex Factors, Thiazoles, Antipsychotic Agents, United States, Multicenter Studies as Topic, Comorbidity, Prevalence, Randomized Controlled Trials as Topic, Treatment Outcome, Diagnosis, Dual (Psychiatry), Conduct Disorder, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review